Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, discuss driving forces for the development of hepatocellular carcinoma, including different types of viral hepatitis and non-alcoholic steatohepatitis.
Updated Breast Cancer Screening Recommendations Pave the Way for a More Equitable Future
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
PROs Underscore Utility of Mirvetuximab Soravtansine in FRα+ Ovarian Cancer
FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer
Personalized Dosimetry With Y-90 Glass Microspheres Shows Positive Activity in HCC
Iglesia Spotlights the Current Complexities of Treatment Sequencing in Advanced HCC
Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer
Addition of Denosumab to Neoadjuvant Chemo Does Not Lead to Significant iDFS Differences in Early Breast Cancer
Capivasertib/Fulvestrant Improves PFS2 in Pretreated PIK3CA/AKT1/PTEN+ HR+/HER2– Breast Cancer